Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Health News

Boehringer, Vitae partner on Alzheimer's drugs

Jun. 15, 2009
German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even halt progression of Alzheimer's disease. The deal could be worth roughly $250 million to...
Related Stories from UPI.com

Licorice may offer colon cancer prevention

NASHVILLE, March 24 (UPI) -- A chemical component of licorice may offer a new way to prevent colorectal cancer without the adverse side effects of other therapies, U.S. researchers said.

Drugs linked to gambling compulsion

DURHAM, N.C., Feb. 15 (UPI) -- Parkinson's disease patients who take anti-tremor drugs are at greater risk of becoming pathological gamblers, Duke University and federal researchers say.

Indian companies eye German drugmaker

BOMBAY, Nov. 14 (UPI) -- Indian pharmaceutical companies are eyeing Germany's fourth largest generic drugmaker, betapharm Arzneimittel GmbH.

Johnson and Johnson touts new drugs

NEW BRUNSWICK, N.J., May 27 (UPI) -- New Jersey's Johnson & Johnson says it has 17 new medicines in advanced stages of clinical testing or awaiting regulatory approval.

Generic drugmaker recalls, halts output

CRANBURY, N.J., May 24 (UPI) -- New Jersey prescription generic drugmaker, Able Laboratories Inc. said Tuesday it was suspending manufacturing and recalling its product line.
1 of 20
Vietnam Veterans Memorial Visited in Washington
View Caption
Veterans etch the names of their friends inscribed on the Vietnam Veterans Memorial on the 50th anniversary of the Vietnam War on May 26, 2012 in Washington, DC. More than 58,000 names of the servicemen who were killed or missing in the war are engraved on The Wall. UPI/Pat Benic